Research Alliance Corp. II (RACB) Stock Analysis

What Research Alliance Corp. II does

Research Alliance Corp. II currently conducts no significant commercial operations. Its primary objective is to complete a strategic business combination, which may involve a merger, a capital stock exchange, the acquisition of assets, a stock purchase, a reorganization, or a similar transaction with one or more businesses. The company focuses on identifying and acquiring an entity primarily within the healthcare sector, particularly emphasizing the biotechnology industry. Established in 2020, Research Alliance Corp. II maintains its headquarters in Las Vegas, Nevada.

Key metrics

ETFs linked to RACB

Broad-market and Financial Services sector ETFs an investor holding Research Alliance Corp. II is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how RACB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Research Alliance Corp. II?

Research Alliance Corp. II trades under the ticker RACB on NASDAQ.

Which exchange is RACB listed on?

RACB is listed on NASDAQ.

What sector does Research Alliance Corp. II operate in?

Research Alliance Corp. II is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze RACB in a portfolio?

PortView shows RACB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.